Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Significance of Pre-Transplant Controlling Nutritional Status Score
Authors:
- Sıdıka Gülkan ÖzkanSÖSıdıka Gülkan Özkan
- Suna AvcıSASuna Avcı
- Ali KimiaeiAKAli Kimiaei
- Seyedehtina SafaeiSSSeyedehtina Safaei
- Yüksel AltuntaşYAYüksel Altuntaş
- Aslı Yüksel ÖztürkmenAÖAslı Yüksel Öztürkmen
- Zeynep Aslı DurakZDZeynep Aslı Durak
- Sinem ÖzdemirSÖSinem Özdemir
- Mohammad Adeeb AbbaraMAMohammad Adeeb Abbara
- Tuğba AğyolTATuğba Ağyol
- Mehmet Serdar YıldızMYMehmet Serdar Yıldız
- Hasan Atilla ÖzkanHÖHasan Atilla Özkan
Open Access
Abstract
Nutritional status is an important prognostic factor in patients with multiple myeloma (MM). The Controlling Nutritional Status (CONUT) score has shown promise in predicting outcomes in various malignancies; however, its role in autologous stem cell transplantation (ASCT) in patients with MM remains unclear. This study aimed to evaluate the significance of pre-transplant CONUT scores in predicting post-transplant engraftment kinetics and early complications in patients with MM undergoing ASCT. This single-center, retrospective study analyzed 59 multiple myeloma patients who underwent ASCT between 1 October 2022, and 1 July 2024. Pre-transplant CONUT scores were calculated, and their associations with various post-transplant outcomes were assessed using statistical analyses. Higher CONUT scores were independently associated with longer neutrophil engraftment times (p = 0.012). Patients who developed oral mucositis (OM) had significantly higher CONUT scores than those without OM (p = 0.028). A CONUT score cut-off of 2.5 demonstrated 100% sensitivity and 57.14% specificity in predicting OM (Area Under the Curve (AUC) 0.792, 95% CI: 0.654–0.930, p = 0.033). Our study demonstrates that a higher pre-transplant CONUT score is significantly associated with a delay in neutrophil engraftment and an increased risk of developing oral mucositis. These findings suggest that the CONUT score can serve as a valuable predictive tool for early post-transplant complications, thereby guiding targeted interventions and improving patient management.Keywords
This publication has 27 references indexed in Scilit:
- Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipientsHematology/Oncology and Stem Cell Therapy, 2020
- Clinical impact of the CONUT score in patients with multiple myelomaAnnals of Hematology, 2019
- Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myelomaAnnals of Hematology, 2019
- Immune Dysfunction as a Cause and Consequence of MalnutritionTrends in Immunology, 2016
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory GroupJournal of Clinical Oncology, 2008
- Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive modelBone Marrow Transplantation, 2006
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trialBlood, 2002
- Reporting results of cancer treatmentCancer, 1981